Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on Capital EmployedReturn on Invested CapitalTimes Interest Earned

Lifecore Biomedical, Inc. \De\ (LFCR) Asset Utilization Ratio (2016 - 2025)

Lifecore Biomedical, Inc. \De\ has reported Asset Utilization Ratio over the past 15 years, most recently at 0.54 for Q2 2025.

  • Quarterly results put Asset Utilization Ratio at 0.54 for Q2 2025, up 5.35% from a year ago — trailing twelve months through May 2025 was 0.54 (up 5.35% YoY), and the annual figure for FY2025 was 0.52, up 3.37%.
  • Asset Utilization Ratio for Q2 2025 was 0.54 at Lifecore Biomedical, Inc. \De\, up from 0.53 in the prior quarter.
  • Over the last five years, Asset Utilization Ratio for LFCR hit a ceiling of 0.54 in Q2 2025 and a floor of 0.24 in Q2 2021.
  • Median Asset Utilization Ratio over the past 5 years was 0.42 (2023), compared with a mean of 0.42.
  • Biggest five-year swings in Asset Utilization Ratio: crashed 83.12% in 2021 and later skyrocketed 65.85% in 2022.
  • Lifecore Biomedical, Inc. \De\'s Asset Utilization Ratio stood at 0.28 in 2021, then skyrocketed by 44.16% to 0.4 in 2022, then grew by 13.83% to 0.46 in 2023, then increased by 13.97% to 0.52 in 2024, then increased by 3.67% to 0.54 in 2025.
  • The last three reported values for Asset Utilization Ratio were 0.54 (Q2 2025), 0.53 (Q1 2025), and 0.52 (Q4 2024) per Business Quant data.